Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.52 |
| ▸ | LSS | P48449 | 1/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18604116 | 0.94 | DNM1 (0.64) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL18604191 | 0.94 | DNM1 (0.64) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrabuthylammonium SCHEMBL1714090 | 0.93 | SLC22A1 (0.57) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL10909488 | 0.83 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL3039163 | 0.83 | SLC22A1 (0.77) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL7636210 | 0.80 | SLC22A1 (0.72) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrapentylammonium SCHEMBL10909204 | 0.80 | SLC22A1 (0.67) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Water SCHEMBL590034 | 0.80 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL14250018 | 0.78 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL7635090 | 0.78 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2279172-B1 | USE OF IONIC LIQUIDS WITH TETRACYANOBORATE ANIONS AS A SOLVENT FOR EXTRACTION OF ALCOHOLS FROM AQUEOUS SOLUTIONS | MERCK PATENT GMBH (DE) | 2013-06-26 | — | — | EP | claimed |
| US-8455703-B2 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GMBH (DE) | 2013-06-04 | — | — | US | claimed |
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GESELLSCHAFT (DE) | 2011-03-24 | — | — | US | claimed |
| US-8455703-B2 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GESELLSCHAFT (DE) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | ADH1C, SLC6A6, ADH5 | SLC22A1 951/4885ALDH1A1 1093/4885TP53 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.